Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC
Finland
99924535.0
Filed on 1999-05-28
99924535.0
Filed on 1999-05-28
Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC
Spain
99924535.0
Filed on 1999-05-28
99924535.0
Filed on 1999-05-28
Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC
Denmark
99924535.0
Filed on 1999-05-28
99924535.0
Filed on 1999-05-28
Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC
Germany
99924535.0
Filed on 1999-05-28
99924535.0
Filed on 1999-05-28
Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC
Switzerland
99924535.0
Filed on 1999-05-28
99924535.0
Filed on 1999-05-28
Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC
Belgium
99924535.0
Filed on 1999-05-28
99924535.0
Filed on 1999-05-28
Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC
Austria
99924535.0
Filed on 1999-05-28
99924535.0
Filed on 1999-05-28
Use of ERBB4 As A Prognostic And Therapeutic Marker For Melanoma
US Patent 8,652,787
Filed on 2011-07-18
Filed on 2011-07-18
Use of ERBB4 as a Prognostic and Therapeutic Marker for Melanoma
European Patent
09791233.1
Filed on 2009-08-06
09791233.1
Filed on 2009-08-06
Use of ERBB4 as a Prognostic and Therapeutic Marker for Melanoma
Australia
2009314534
Filed on 2009-08-06
2009314534
Filed on 2009-08-06